Mail

UK markets close in 43 minutes

FTSE 100
8,212.28
+40.13(+0.49%)
FTSE 250
20,180.86
+128.53(+0.64%)
AIM
771.29
+3.18(+0.41%)
GBP/EUR
1.1656
-0.0027(-0.23%)
GBP/USD
1.2548
+0.0015(+0.12%)
Bitcoin GBP
49,254.07
+2,068.64(+4.38%)

11 fabulous farmhouses perfect for living a rural lifestyle

A farmhouse could be your dream home if you’re in search of bucolic bliss

Marinus Pharmaceuticals, Inc. (0JYL.L)

LSE - LSE Delayed price. Currency in USD

Add to watchlist

1.5920

+0.1470

(+10.17%)

As of 03:24PM BST. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	N/A
Enterprise value	N/A
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	N/A
Price/book (mrq)	N/A
Enterprise value/revenue	N/A
Enterprise value/EBITDA	N/A

Trading information

Stock price history

Beta (5Y monthly)	0.89
52-week change ³	44.37%
S&P500 52-week change ³	22.43%
52-week high ³	11.2400
52-week low ³	1.5200
50-day moving average ³	9.7550
200-day moving average ³	8.6992

Share statistics

Avg vol (3-month) ³	499
Avg vol (10-day) ³	277
Shares outstanding ⁵	40.52M
Implied shares outstanding ⁶	N/A
Float ⁸	38.28M
% held by insiders ¹	0.97%
% held by institutions ¹	106.42%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	N/A
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	0.25:1
Last split date ³	23 Sept 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-492.86%

Management effectiveness

Return on assets (ttm)	-38.19%
Return on equity (ttm)	-213.02%

Income statement

Revenue (ttm)	30.99M
Revenue per share (ttm)	0.58
Quarterly revenue growth (yoy)	0.40%
Gross profit (ttm)	N/A
EBITDA	-126.13M
Net income avi to common (ttm)	-141.4M
Diluted EPS (ttm)	-2.4750
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	150.29M
Total cash per share (mrq)	2.75
Total debt (mrq)	110.36M
Total debt/equity (mrq)	658.26%
Current ratio (mrq)	4.07
Book value per share (mrq)	0.31

Cash flow statement

Operating cash flow (ttm)	-118M
Levered free cash flow (ttm)	-70.09M